Dr. Jeffrey R. Jay, M.D. »

Tscan Therapeutics shares owned by Dr. Jeffrey R. Jay, M.D.

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Dr. Jeffrey R. Jay, M.D. from 13F filings

Historical chart of Dr. Jeffrey R. Jay, M.D. investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Dr. Jeffrey R. Jay, M.D.

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.5M 941k 5.85

More positions owned by Dr. Jeffrey R. Jay, M.D.

Urogen Pharma (URGN)
Neurogene (NGNE)
Abivax Sa Sponsored Ads (ABVX)
Merus N V (MRUS)
Pliant Therapeutics (PLRX)
Arcellx Common Stock (ACLX)
Dynavax Technologies Corp Com New (DVAX)
Evolus (EOLS)
Cytokinetics Com New (CYTK)
Dianthus Therapeutics (DNTH)
Insmed Com Par $.01 (INSM)
Zura Bio Class A Ord Shs (ZURA)
Kalvista Pharmaceuticals (KALV)
Ionis Pharmaceuticals (IONS)
Context Therapeutics (CNTX)

View all positions for Dr. Jeffrey R. Jay, M.D.

Top funds holding Tscan Therapeutics

Lynx1 Capital Management
EcoR1 Capital
BlackRock
Adage Capital Partners GP
BVF
Baker Bros. Advisors
Vanguard Group
Propel Bio Management
Deer Management
Alphabet
Simplify Asset Management
Dr. Jeffrey R. Jay, M.D.
Geode Capital Management
Stempoint Capital
LMR Partners

View all funds holding Tscan Therapeutics